ORBIMED ADVISORS LLC

Position in PFE — Pfizer Inc

CIK 1055951 New York, NY

Back to PFE Full portfolio

Position in PFE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$54,657,720

+$13,500,510 QoQ

Shares Held

1,946,500

+17.8% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Sep 30, 2025

CallValue

$12,740,000

CallShares

500,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $634,822,752 across 5 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	257,900	$309,333,022
2	AZN	Astrazeneca PLC	915,700	$173,635,034
3	MRK	Merck & Co., Inc.	663,400	$85,246,900
4	BMY	Bristol Myers Squibb Co	925,000	$53,298,500
5	BIIB	Biogen Inc.	61,600	$13,309,296

All Filings in PFE

Export CSV

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$54,657,720	1,946,500	+17.8%	Shares	Sole	2026-05-15
2025-12-31	$41,157,210	1,652,900	-57.1%	Shares	Sole	2026-02-17
2025-09-30	$12,740,000	500,000	0.0%	Call	Defined	2025-11-14
2025-03-31	$97,564,068	3,850,200	+176.3%	Shares	Sole	2025-05-15
2025-03-31	$12,670,000	500,000	+100.0%	Call	Defined	2025-05-15
2024-12-31	$6,632,500	250,000	0.0%	Call	Defined	2025-02-14
2024-06-30	$6,995,000	250,000	-50.0%	Call	Defined	2024-08-14
2023-12-31	$14,395,000	500,000	-33.3%	Call	Defined	2024-02-14
2022-12-31	$71,408,064	1,393,600	-46.4%	Shares	Sole	2023-02-14
2022-09-30	$113,732,240	2,599,000	-5.3%	Shares	Sole	2022-11-14
2022-06-30	$143,867,920	2,744,000	-29.7%	Shares	Defined	2022-08-15
2022-03-31	$202,187,735	3,905,500	+49.3%	Shares	Defined	2022-05-16
2021-12-31	$154,439,370	2,615,400	-27.7%	Shares	Defined	2022-02-14
2020-12-31	$133,127,046	3,616,600	+20.1%	Shares	Defined	2021-02-16
2020-09-30	$27,524,972	750,000	+50.0%	Call	Defined	2020-11-16
2020-03-31	$98,314,810	3,012,100	—	Shares	Defined	2020-05-15
2020-03-31	$16,319,977	500,000	—	Call	Defined	2020-05-15
No filing history on record for this holder in this stock.